# Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults

> **NCT05269459** · PHASE2 · RECRUITING · sponsor: **University of Nebraska** · enrollment: 180 (estimated)

## Conditions studied

- PTSD

## Interventions

- **DRUG:** Cannabidiol Administered as Nantheia ATL5
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05269459
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2028-12
- **Final completion:** 2029-04
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-05-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05269459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05269459, "Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05269459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*